148 related articles for article (PubMed ID: 36529093)
21. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
[TBL] [Abstract][Full Text] [Related]
23. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
Bosticardo M; Pala F; Notarangelo LD
Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in understanding RAG deficiencies.
Gennery A
F1000Res; 2019; 8():. PubMed ID: 30800289
[TBL] [Abstract][Full Text] [Related]
25. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
[TBL] [Abstract][Full Text] [Related]
26. Congenital defects in V(D)J recombination.
de Villartay JP
Br Med Bull; 2015 Jun; 114(1):157-67. PubMed ID: 25987660
[TBL] [Abstract][Full Text] [Related]
27. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.
Corneo B; Moshous D; Güngör T; Wulffraat N; Philippet P; Le Deist FL; Fischer A; de Villartay JP
Blood; 2001 May; 97(9):2772-6. PubMed ID: 11313270
[TBL] [Abstract][Full Text] [Related]
28. Omenn syndrome due to ARTEMIS mutations.
Ege M; Ma Y; Manfras B; Kalwak K; Lu H; Lieber MR; Schwarz K; Pannicke U
Blood; 2005 Jun; 105(11):4179-86. PubMed ID: 15731174
[TBL] [Abstract][Full Text] [Related]
29. Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.
Kato M; Kimura H; Seki M; Shimada A; Hayashi Y; Morio T; Kumaki S; Ishida Y; Kamachi Y; Yachie A
Allergol Int; 2006 Jun; 55(2):115-9. PubMed ID: 17075247
[TBL] [Abstract][Full Text] [Related]
30. Omenn syndrome caused by a novel homozygous mutation in recombination activating gene 1.
Benhsaien I; Essadssi S; Elkhattabi L; Bakhchane A; Abdelghaffar H; Bousfiha AA; Badou A; Barakat A
Immunobiology; 2021 May; 226(3):152090. PubMed ID: 33964732
[TBL] [Abstract][Full Text] [Related]
31. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.
Tirosh I; Yamazaki Y; Frugoni F; Ververs FA; Allenspach EJ; Zhang Y; Burns S; Al-Herz W; Noroski L; Walter JE; Gennery AR; van der Burg M; Notarangelo LD; Lee YN
J Allergy Clin Immunol; 2019 Feb; 143(2):726-735. PubMed ID: 29772310
[TBL] [Abstract][Full Text] [Related]
32. Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.
Pourvali A; Arshi S; Nabavi M; Bemanian MH; Shokri S; Shahrooei M; Rezaei N; Fallahpour M
Iran J Immunol; 2019 Dec; 16(4):334-338. PubMed ID: 31885011
[TBL] [Abstract][Full Text] [Related]
33. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
34. A RAG1 mutation found in Omenn syndrome causes coding flank hypersensitivity: a novel mechanism for antigen receptor repertoire restriction.
Wong SY; Lu CP; Roth DB
J Immunol; 2008 Sep; 181(6):4124-30. PubMed ID: 18768869
[TBL] [Abstract][Full Text] [Related]
35. RAG Deficiency: Two Genes, Many Diseases.
Delmonte OM; Schuetz C; Notarangelo LD
J Clin Immunol; 2018 Aug; 38(6):646-655. PubMed ID: 30046960
[TBL] [Abstract][Full Text] [Related]
36. Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome.
Gennery AR; Slatter MA; Rice J; Hoefsloot LH; Barge D; McLean-Tooke A; Montgomery T; Goodship JA; Burt AD; Flood TJ; Abinun M; Cant AJ; Johnson D
Clin Exp Immunol; 2008 Jul; 153(1):75-80. PubMed ID: 18505430
[TBL] [Abstract][Full Text] [Related]
37. The genetic and biochemical basis of Omenn syndrome.
Santagata S; Villa A; Sobacchi C; Cortes P; Vezzoni P
Immunol Rev; 2000 Dec; 178():64-74. PubMed ID: 11213808
[TBL] [Abstract][Full Text] [Related]
38. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.
de Villartay JP; Lim A; Al-Mousa H; Dupont S; Déchanet-Merville J; Coumau-Gatbois E; Gougeon ML; Lemainque A; Eidenschenk C; Jouanguy E; Abel L; Casanova JL; Fischer A; Le Deist F
J Clin Invest; 2005 Nov; 115(11):3291-9. PubMed ID: 16276422
[TBL] [Abstract][Full Text] [Related]
39. B cell abnormalities and autoantibody production in patients with partial RAG deficiency.
Min Q; Csomos K; Li Y; Dong L; Hu Z; Meng X; Yu M; Walter JE; Wang JY
Front Immunol; 2023; 14():1155380. PubMed ID: 37475856
[TBL] [Abstract][Full Text] [Related]
40. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation.
Hönig M; Schwarz K
Curr Opin Rheumatol; 2006 Jul; 18(4):383-8. PubMed ID: 16763459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
